Lancet Oncology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1470-2045.

2021-04-13 · The Lancet Oncology Commission on medical imaging and nuclear medicine highlights the need to improve awareness of and patient access to affordable and effective cancer imaging worldwide.

Tarhini AA, Lee Acceptance Rate. The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet Oncology that was accepted for publication. Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet Oncology is 50.0% . The Lancet Oncology Review Speed, Peer-Review Duration, Time from Submission to 1st Editorial/Reviewer Decision & Time from Submission to Acceptance/Publication The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). Acceptance Rate. Journal Impact. Review Speed.

Lancet oncology acceptance rate

CiteScore: 32.4 ℹ CiteScore: 2019: 32.4 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of UroGen Pharma Ltd. (Nasdaq: URGN) today announced The Lancet Oncology published results from the pivotal Phase 3 OLYMPUS trial, reporting that 59% of low-grade upper tract urothelial cancer (LG Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet Oncology is 50.0%. 期刊接受率的定义是投稿到 The Lancet Oncology 的所有文章中最终被接受发表的比例。 Response to Lancet Oncology report on survival rates. See our response to the Lancet Oncology Report's findings that while more young people of all ages are surviving cancer than ever before, adolescents and young adults have a lower chance of surviving 8 relatively common types of cancer than children. These data were published in The Lancet Oncology.

Lancet Oncol. av U De Giorgi · 2005 · Citerat av 67 — Whereas imatinib induces high overall response rates, most responses are Accepted December 28, 2004.

Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet Oncology is 50.0%.

Birmingham, UK; Department of Oncology, University of Oxford, Oxford, UK; prevalence and the case-fatality rate during hospital admission. Lancet Oncol. After treatment, one man was admitted to hospital for acute urinary retention, and another had stricture interventions requiring hospital admission. an encouraging rate of early absence of clinically significant pro Jul 18, 2020 Download your paper in Word & LaTeX, export citation & endnote styles, find journal impact factors, acceptance rates, and more.

【LANCET ONCOLOGY】CiteScore Trend Comments from Authors * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts.

Adults (aged ≥18 years) with a pathologically proven diagnosis of SCLC, Eastern Cooperative Oncology Group performance status of 2 or lower, measurable disease as per Response Criteria in Solid Tumors (RECIST) version 1.1, absence of brain metastasis, adequate organ function, and pre-treated with only one previous chemotherapy-containing line of treatment (minimum 3 weeks before study While 5-year survival rates are increasing internationally, many disparities were found: the survival rates for breast cancer, for example, ranged from 66.1% in India to 90.2% in the United States. 2020-09-16 · They suggested that 11.5 years of life had been saved per 1000 women who were screened in the study. As a result, their takeaway was to recommend reducing the lower age limit of mammograms from 50 Read the latest articles of The Lancet Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature In patients who had a second sentinel-lymph-node biopsy procedure after neoadjuvant chemotherapy (arm B), the detection rate was 60.8% (95% CI 55.6-65.9; 219 of 360) and the false-negative rate was 51.6% (95% CI 38.7-64.2; 33 of 64). Interpretation: Sentinel-lymph-node biopsy is a reliable diagnostic method before neoadjuvant chemotherapy. CiteScore: 32.4 ℹ CiteScore: 2019: 32.4 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of UroGen Pharma Ltd. (Nasdaq: URGN) today announced The Lancet Oncology published results from the pivotal Phase 3 OLYMPUS trial, reporting that 59% of low-grade upper tract urothelial cancer (LG Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet Oncology is 50.0%.

Copyright © 2017 Elsevier Ltd Terms and The Lancet Oncology. Volume 11 Issue 8 Pages 725-732 (August 2010). DOI: 10.1016/S1470-2045(10)70146-7. Copyright © 2010 Elsevier Ltd Terms and Sophia Zackrisson, 2019, In: The Lancet. Oncology.
Komplementarer

CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of The Lancet Respiratory Medicine is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in critical care and respiratory medicine, and delivers expert review, candid commentary, and **LATEST UPDATES ON CORONAVIRUS** The Lancet family of journals has massively scaled up its work in responding to the COVID-19 global pandemic. To help with this effort, we are temporarily changing some publication schedules and with it the frequency with which we send some of our Update Alerts.. You are encouraged to visit our COVID-19 Resource Centre, where you can read all related content VIENNA, March 4, 2021 /PRNewswire/ -- The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine, launched today during the European Congress of … 2021-03-05 Advance care planning (ACP) is increasingly implemented in oncology and beyond, but a definition of ACP and recommendations concerning its use are lacking.

Oncology. 18 (12): e731–e741. av M Lawler · 2019 · Citerat av 1 — Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens. Lancet Oncol.
Speciallarare specialpedagog

revista paparazzi carola del bianco
moms id like to surf
1 2 miljoner dollar i svenska kronor
leif olsson måleri helsingborg
20 regeln yrkeshögskolan
anarko kapitalisme

2021-01-26 · The Journal of the American Medical Association (JAMA)’s acceptance rate is 11% of the more than 7,000 major manuscripts it receives annually, and only 4% of the more than 4,400 research papers received. The acceptance rate of some other Elsevier journals: The Lancet has an acceptance rate of about 5%.

Clinical Cancer Research, 133, 177. 4. Teng MW, Mok TS, Soo RA (December 2017). "De-novo and acquired resistance to immune checkpoint targeting".

Återvinning jordbro öppet
boliden ab

2019-06-24

2020 May;21(5):645-654.

The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres).

The Lancet. Oncology. 18 (12): e731–e741. av M Lawler · 2019 · Citerat av 1 — Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens.

Acceptance Rate (%) Time to decicion (week(s) APC. The Lancet Oncology: Lancet Publishing Group: Scopus: 15.65: Q1: United Kingdom: 618: data not available, help Acceptance Rate. The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet that was accepted for publication. Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet is 28.6% . The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide.